IS GLYCEMIC CONTROL IN PATIENTS WITH TYPE-2 DIABETES IN RAWALPINDI IMPROVING?

Authors

  • Dilshad Ahmed Khan
  • Mariam Saeed
  • Farooq Ahmad Khan

Abstract

Background: Glycaemic control is critical for managing diabetes and related complications.Considering high prevalence of Diabetes in Pakistan, our study aimed to assess the status ofglycaemic control in Type-II Diabetics by measurement of HbA1c from 2005–2007 atRawalpindi. We also evaluated changes in its trends in relation with sex and age. Methods: It wasa retrospective analysis of data from Clinical Pathology Laboratory, Army Medical College,Rawalpindi during 2005–2007. A total of 2875 patients, aged 24–70 years, taking oralhypoglycaemic agents, were included. HbA1c was measured by using Human kit. InternationalDiabetes Federation guidelines, ≤6.5%, 6.6%–8.4% and ≥8.5% were used to classify patients intogood, fair and poor control categories. Results: The number of patients (n=2875) tested forHbA1c increased from 904,974 to 997 during 2005–2007. The patients had an age of 48±13 yearsand comprised of 54% males and 46% females. Improvement in patient’s glycaemic controlamong the three categories during 2005 to 2007 was as follows: good (41% vs 47%), fair (38% vs40%) and poor (21% vs 13%) respectively. The average HbA1c values improved from 7.25 % in2005 to 6.69% in 2007 (p<0.05). Overall, males (45%) and youngest age group (53%) patients hadgood diabetic control. Conclusion: Glycaemic control improved in diabetic patients from 41% to47% during 2005–2007 at Rawalpindi. Males, especially the youngest patients comprised majorityof good control population. For effective disease management and optimal HbA1c values, acombined effort by the patient and physician is required.Keywords: Diabetes, Glycaemic Control, HbA1c, IDF guidelines, Pakistani population

References

Hossain P, Kawar B, EI Nahas M. Obesity and diabetes in the

developing world-A growing challenge. N Engl J Med

;356(3):213–15.

Hoerger TJ, Segel JE, Gregg EW, Saadine JB. Is Glycemic

control improving in US adults? Diabetes Care

;31(1):81–6.

Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley

SE, A Cull CA, et al. Association of glycemia with

microvascular and macro vascular complications of type 2

diabetes mellitus (UKPDS 35): Prospective observational

study. BMJ 2000;321:405–12.

Klein R ,Klein BE ,Moss SE. Relation of glycemic control to

diabetic microvascular complications in diabetes mellitus.

Ann Intern Med 1996;124(1):90–6.

KleinR. Hyperglycemia and microvascular and

macrovascular disease in diabetes . Diabetes Care

;18(2):258–68.

Gilmer TP, O Connor PJ, Manning WG, Rush WA. The cost

to health plans of poor glycemic control. Diabetes Care

;20(12):1847–53.

Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens

DK. Glycemic Control and Type 2 Diabetes Mellitus: The

Optimal Haemoglobin A1c Targets. A Guidance Statement

from the American College of Physicians. Annals of Internal

Medicine 2007;147(18):417–22.

IDF Clinical Guidelines Task Force. Global guideline for Type

diabetes. Brussels: International Diabetes Federation, 2005.

Sulaiman S, Mokhtar NA, Ismail J, Ismail AA, Bebakar WM,

Mohammad M. Glycemic control among type 2 diabetic

patients in Kelantan. NCD Malaysia 2004;3(3):2–5.

Lantion-Ang LC. Epidemiology of diabetes mellitus in

Western Pacific region: focus on Philippines. Diabetes Res

Clin Pract 2000;50(2):S29 –S34.

Liebl A, Mata M, Eschwège E. Evaluation of risk factors for

development of complications in Type II diabetes in Europe.

Diabetologia 2002;45:S23–S28.

Sanabria MC, Rodriguez J, Badia X, Novials A.

Epidemiological study on glycemia control in patients with

DM1 and DM2, Epicon study- baseline visit analysis.

Endocrine Abstracts 2004;8:30.

Nishtar S, Shera S. Diabetes prevention and control as a part

of an integrated non-communicable disease strategy: the

Pakistan approach. Pract Diabetes Int 2006;23(8):332–4.

Habib SS ,Aslam M. Risk factors, knowledge and health

status in diabetic patients. Saudi Med J 2003;24:1219–24.

Badruddin N, Basit A, Hydrie M, Hakeem R. Knowledge,

Attitude and Practices of Patients Visiting a Diabetes Care

Unit. Pak J Nutrition 2002;1(2):99–102.

Basit A, Hydrie M, Hakeem R, Ahmedani MY, Masood Q.

Frequency of chronic complications of type 2 diabetes. J Coll

Physicians Surg Pak 2004;14(2):79–83.

Mahmood K, Amir AH. Glycemic control status in patients

with type-2 diabetes. J Coll Physicians Surg Pak

;15(6):323–5.

The Effect of Intensive Treatment of Diabetes on the

Development and Progression of Long-Term Complications

in Insulin-Dependent Diabetes Mellitus. N Engl J Med

;329:977–86.

Afridi MA, Khan MN. Role of health education in the

management of diabetes mellitus. J Coll Physician Surg Pak

;13:558–61.

ChuangLM, Tsai ST, Huang BY, Tai TY. The status of

diabetes control in Asia-a cross sectional survey of 24317

patients with diabetes mellitus in 1998. Diabetic Med

;19:978–85.

Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S.

Prevalence of inadequate Glycemic control among patients

with diabetes in the United Kingdom general practice

research data base: a series of retrospective analysis of data

from 1998–2002. Clinl Ther 2006;28(3):388–95.

Harris SB, Worrall G, Macaulay A, Norton P, WebsterBogaert S, Donner A, et al. Diabetes Management in Canada:

Baseline Results of the Group Practice Diabetes Management

Study. Can J Diabetes 2006;30(2):131–7.

Mark T, Andrew J, Merlin C. The management of diabetes in

Indigenous Australians from primary care. BMC Public

Health 2007;7:303.

Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A,

Yamauchi M et al. The status of diabetes control and

antidiabetic drug therapy in Japan-A cross-sectional survey

of 17,000 patients with diabetes mellitus (JDDM 1). Diabetes

Research and Clinical Practice 2006;73:198–204.

Siddique H, Tahrani A ,Scarpello J. Does poor adolescent

diabetic control result in poor adult control? Endocrine

Abstracts. 2008;15:119.

Patel A, MacMahon S, Chalmers J, Neal B, Billot L,

Woodward M, et al. Intensive blood glucose control and

vascular outcome in patients with type 2 diabetes. N Engl J

Med 2008;358(24):2560–72.

Gerstein HC, Miller EM, Byington RP, Goff DC, Bigger JT,

Buse JB, et al. Effects of intensive glucose lowering in type 2

diabetes. N Engl J Med 2008;358(24):2545–59.

Sabri A, Qayyum M, Saigol N, Zafar K, Aslam F. Comparing

knowledge of diabetes mellitus among rural and urban

diabetics. Mcgill J Med 2007;10(2):87–9.

Khowaja AL, Khuwaja AK, Cosgrove P. Cost of diabetes

care in out-patient clinics of Karachi, Pakistan. BMC Health

Serv Res 2007;7:189.

Published

2009-03-01

Most read articles by the same author(s)